Apoptosis/programmed cell death: A historical perspective

Advances in Experimental Medicine and Biology

Volumn 406, Issue , 1996, Pages 1-9

  Gupta, Sudhir ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; APOPTOSIS; GENE; GENETICS; HUMAN; REVIEW;

ANIMALS; APOPTOSIS; GENES; HUMANS;

EID: 0030347039     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4899-0274-0_1     Document Type: Article

References (88)

1. Virchow R. Cellular Pathology as Based Upon Physiological and Pathological Histology. Ed. 2 (translated from German by B. Chance, 1859); reproduced by Dover Publications, New York pp 356 ( 1971 ).
2. Weigert C. Über Croup und Diphtheritis. Ein experimeteller und anatomischer Beitrag zur Pathologie der specifischen Entzundungsformen. Virchows Arch. Pathol. Anat. 72: 461 (1877-1878)
3. Flemming W. Über die Bildung von Richtungsfiguren in Saugethiereiern beim Untergang Graaf'scher Follikel. Arch Anat EntwGesh 221 ( 1885).
4. Nissen F. Über das Verhalten der Kerne in den Milchdrusenzellen bei der Absonderung. Arch Mikroskop Anat. 26: 337(1886).
5. Arnheim G. Coagulationsnekrose und Kernschwund. Virchows Arch Path. Anat. 120: 367 (1890).
6. Stöbe H. Zur Kenntnis verschiedener cellularer Vorgange und Erscheinungen in Geschwulsten, Beitr. Pathol. Anat. 11: l (1914).
7. Grapher L. Eine neue Anschauung über physiologische Zellausschaltung. Arch. Zellforsch 12: 373 (1914).
8. Glucksmann A. Cell death in normal vertebrate ontogeny. Biol. Rev. Camb. Philos. Soc. 26: 59 (1951).
9. Majno G., La Gattuta M., Thompson T.E. Cellular death and necrosis: chemical, physical and morphologic changes in rat liver. Virchows Arch. Pathol. Anat. 333: 421 (1960).
10. Majno G. and Joris I. Cells, Tissues and Disease: Principles of General Pathology. Blackwell Science, Inc. (in press)
11. Kerr J.F.R. A histochemical study of hypertrophy and ischémie injury of rat liver with special reference to changes in lysosomes. J. Pathol. Bactriol. 90: 557 (1965).
12. Kerr J.F.R. An electron-microscope study of liver cell necrosis due to heliotrine. J. Pathol. 97:557(1969).
13. Kerr J.F.R. Shrinkage necrosis: a distinct mode of cellular death. J. Pathol. 105: 13(1971).
14. Kerr J.F.R., Wyllie A.H., and Currie A.R. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Brit. J. Cancer 26: 239 (1972).
15. Cohen L.J. and Ellis M.E. Radiation-induced changes in tissue nucleic acids: release of soluble deoxynucleotides in the spleen. Radiât. Res. 7: 508 (1957).
16. Skalka M. and Matyasova J. The effect of low radiation doses on the release of deoxyribonucleotides in hematopoietic and lymphatic tissues. Int. J. Radiât. Biol. 7: 41 (1963).
17. Vodolazskaya N.A. and Vermolaeva N.V. Investigation of DNP degradation produced by y-irradiation, hydrocortisone and degranol in rat thymus. Radiobiologiya 11: 335 ( 1971 ).
18. Saunders J.W. Jr. Death in embryonic systems. Science 154: 604 (1966).
19. Lockshin R.A. and Williams C.W. Programmed cell death. I. Cytology of generation in the intersegmental muscles of the Pernyi Silkmoth. J. Insect Physiol. II: 123(1965).
20. Lockshin R.A. & Williams C.M. Programmed cell death II. Endocrine potentiation of the breakdown of the intersegmental muscles of silkworm. J. Insect Physiol. 10: 643 (1964).
21. Skalka M., Matyasova J., Cejkova M. DNA in chromatin of irradiated lymphoid tissues degrades in vivo into regular fragments. FEBS Lett. 72: 271 (1976).
22. Yamada T., Ohyama H., Kinjo Y., Watanabe M. Evidence for internucleosomal breakage of chromatin in rat thymocytes irradiated in vitro. Radiât. Res. 85: 544 (1981).
23. Zhivotovsky B.D., Zvonareva N.B., Hanson K.P. Characteristics of rat thymus chromatin degradation products after whole body irradiation. Int. J. Rad. Biol. 39: 437 (1981).
24. Wyllie A.H., Morris R.G., Smith A.L., Dunlop D. Chromatin cleavage in apoptosis: association with condensed chromatin morphology and dependence on macromolecular synthesis. J. Pathol. 142: 67-77, 1984
25. Pachatnikov V.A., Afanasyev V.N., Korol B.A., Korneev V.N., Rochev Y.A., and Umansky S.R. Flow cytometry analysis of DNA degradation in thymocytes of y-irradiation or hydrocortisone treated rats. Gen. Physiol. Biophys. 5: 273 (1986).
26. Afanasyev V.N., Korol B.A., Mantsygin Y.A., Nelipovich P.A., Pechatnikov V.A. and Umansky S.R. Flow cytometry and biochemical analysis of DNA degradation characteristics of two types of cell death. FEBS Lett. 194: 347(1986).
27. Sulston J.E. and Horvitz H.R. Post embryonic lineages of the nematode Caenorhabditis elegans. Dev. Biol. 82: 110(1977).
28. Ellis H.M. and Horvitz H.R. Genetic control of programmed cell death in the nematode C. elegans. Cell 44: 817 (1986).
29. Yuan J. and Horvitz H.R. The Caenorhabditis elegans gene Ced-3 and Ced-4 act autonomously to cause programmed cell death. Dev. Biol. 138: 33 (1990).
30. Yuan J., Shaham S., Ledoux S., Ellis J.M. and Horvitz H.R. The C. elegans cell death gene Ced-3 encodes a protein similar to mammalian interleukin-l converting enzyme. Cell 75: 641 (1993).
31. Miura M., Zhu H., Rotello R., Hartwieg E.A. & Yuan J. Induction of apoptosis in fibroblasts by IL-1 beta-converting enzyme, a mammalian homolog of the C.elegans cell death gene ced-î. Cell 78:653-660, 1993.
32. Henkart P.A. ICE family proteases: mediators of all apoptotic cell death. Immunity 4: 195 (1996).
33. Nicholson D.W., Ali A., Thornberry N.A., Vaillancourt J.P, Ding C.K., Gallant M., Gareau Y, Griffin P.R., Labelie M., Lazebnik Y.A., Munday N.A., Raju S.M., Smulson M.E., Yamin T-T., Yu V.L. and Miller O.K. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 376: 37(1995)
34. Hengartner M.O., Ellis R.E. and Horvitz H.R. Caenorhabditis elegans gene ced-9 protects cells from programmed cell death. Nature 356: 494 (1995).
35. Hengartner M.O., & Horvitz H.R. C. elegans cell survival gene Ced-9 encodes a functional homologue of the mammalian proto-oncogene bcl-2. Cell 76: 665 (1994).
36. Tsujimoto Y., Finger L.R., Yunis J., Nowell P.C. and Croce C.M. Cloning of chromosomes break point of neoplastic B cells with the t(14:18) chromosome translocation. Science 226: 1097 (1989)
37. Tsujimoto Y. & Crocc C.M. Analysis of structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma. Proc. Natl. Acad. Sei. (USA) 83: 5214 (1985).
38. Chen-Levy Z., Nourse J.. and C'leary M.L. The bcl-2 candidate proto- oncogene product is a 24-kilodalton integral membrane protein highly expressed in lymphoid cell lines and lymphomas carrying the (14:18) translocation. Mol. Cell Biol. 9: 701 (1989).
39. Hockenbery M.O., Nunez Z., Milliman C., Schreiber R.D., and Korsmeyer S.J. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348: 334 (1990).
40. Chen-Levy Z. and Cleary M.L. Membrane topology of the Bcl-2 proto- oncogene protein demonstrated in vitro. J. Biol. Chcm. 265: 4929 (1990).
41. Siegal R.M.. Katsumata M.. MiyashitaT., Louie D.C'., Greene M.L, and Reed J.C. Inhibition of thymocyte apoptosis and negative antigenie selection in bcl-2 transgene mice. Proc. Natl. Acad. Sei. (USA) 89: 7003 (1992).
42. Strasser A., Harris A.W., & Cory S. bcl-2 transgene inhibits T cell death and perturbs thymic self censorship. Cell 67: 889 (1991).
43. Vox D.L., Cory S., and Adams J. Bcl-2 gene promotes haematopoietic cell survival and cooperates withr-mvc to immortalize pre-B cells. Nature 335: 440 (1988).
44. Nunez G.. Hockenbery D., McDonnell T.J.. Sorensen C.M., and Korsmeyer S.J. Bcl-2 maintains B cell memory. Nature 353: 71 (1991).
45. Strasser A., Harris A.W., Corcoran L.M., and Cory S. Bcl-2 expression promotes B but not T-lymphoid development in SC1D mice. Nature 368: 457 (1994).
46. Takayama S.. Sato T., Krajewski S., Kochel K.. Irie S.. Millan J. and Reed J. Cloning and functional analysis of BAG-1: a novel Bcl-2 binding protein with anti-cell death activity. Cell 80: 279 ( 1995).
47. Boise L.H., Gonzalez-Garcia M., Postema C.E., Ding L., Lindsten T.. Turka L.A.. Mao X., Nunez G., and Thompson C. bcl-x,a bcl-2 related gene that functions as a dominant regulator of apoptotic cell death. Cell 74: 597(1993).
48. Oltvai Z.N., Miliman C., and Korsmeyer S.J. Bcl-2 heterodimerizes in vivo with a conserved homologue, Bax, that accelerates programmed cell death. Cell 74: 609 (1993).
49. Kozopas K.M., Yang T., Buchan H.L., Zhou P., and Craig R.W. MCL 1, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to Bcl-2. Proc. Natl. Acad. Sei. (USA) 90: 3516 (1993).
50. Lin E.Y, Orlofsky A., Berger M.S., Prystowsky. Characterization of Al, a novel hematopoetic-specific early-response gene with sequence similarity to bcl-2. J. Immunol. 151: 1979 (1993).
51. Yonish-Rouach E., Resnizky D., Lotem J., Sachs L., Kimchi A., and Oren M. Wild-type p53 induces apoptosis in myeloid leukemic cells that is inhibited by interleukin-6. Nature 352: 345 (1991).
52. Lowe S.W., Schmitt E.M., Smith S.W., Osborne B.A., and Jacks T. p53 is required for irradiation-induced apoptosis in murine thymocytes. Nature 362: 847 (1993).
53. Clarke A.R., Purdie C.A., Harrison D.J.. Morris R.G.. Bird C.C.. Hooper M.L., and Wyllie A.H. Thymocyte apoptosis induced by p63 dependent and independent pathways. Nature 362: 849 (1993).
54. Chiou S.K.. Rao L., and White E. Bcl-2 blocks p53-dependent apoptosis. Mol. Cell. Biol. 14: 2556 ( 1994).
55. Miyashita T., Krajewski S., Krajewska M., Wang H.G., Lin H.K., Liebermann D.A., Huffman B., and Reed J.C. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 9: 1799(1994).
56. Miyashita T., Harigai M., Hanada M., and Reed J.C. Identification of a p53- dependent negative response element in the bcl-2 gene. Cancer Res. 54: 3131 (1994).
57. Shi Y, Glynn J., Guilbert L.J.. Cotter T.G., Bisonette R.P., and Green D.R. Role of c-myc in activationinduced apoptotic cell death in T-cell hybridoma. Science 257: 212 (1992).
58. Evan G.I., Wyllie A.H.. Gilbert C.S., Lttlewood T.D., Land H., Brooks M., Waters C.M., Penn L.Z. and Hancook D.C. Induction of apoptosis in fibroblasts by c-myc protein. Cell 69: 119 (1992).
59. Bissonnette R.P.. Echeverri F., Mahboubi A., and Green D.R. Apoptotic cell death induced by c-myc is inhibited by bcl-2. Nature 359: 352 (1992).
60. Fanidi A.. Harrington E.A., and Evan G.I. Cooperative interaction between c-myc and bcl-2 proto-oncogenes. Nature 359: 554 (1992).
61. Trauth B.C., Klas C., Peters A.M.J., Matzku S., Moller P., Falk W., Debatin K.M., and Krammer P.H. Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 245: 301 (1989).
62. Yonehara S., Ishi A., and Yonehara M. A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J. Exp. Med. 169: 1747 ( 1989).
63. N., Yonehara S., Ishii A.. Yonehara M., Mizushima S.I., Sameshima M., Hase A., Seto Y. & Nagata S. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66: 233 (1991).
64. Oehm A., Behrmann I., Falk W., Pawlita M., Maier G., Klas C., Li-Weber M., Richards S., Dhein J., Trauth B.C., Ponsting H., and Krammer P.H. Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily. Sequence identity with the Fas antigen. J. Biol. Chem. 67: 10709 (1992).
65. Watanabe-Fukunaga R., Brennan C.I., Itoh N., Yonehara S., Copeland N.G., Jenkins N.A., and Nagata S. The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen. J. Immunol.148: 1274(1992).
66. Itoh N. and Nagata S. A novel protein domain required for apoptosis.J. Biol. Chem. 268: 10932 (1993).
67. Tartaglia L.A., Ayres T.M., Wong G.H.W., and Goeddel D.V. A novel domain within the 55 kd TNF receptor signals cell death. Cell 74: 845 (1993)..
68. Enari M., Hug H. and Nagata S. Involvement of an ICE-like protease in Fas- mediated apoptosis. Nature 375: 78 (1995).
69. Chennaiyan A.M., O'Rourke K., Tiwari M. and Dixit V. FADD, a novel death-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 61: 505 ( 1995).
70. Stanger B.Z.. Leder P., Lee T Kim E., Seed B. RIP: a novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death. Cell 81: 515 (1995).
71. Sato T.. Irie S.. Kitada S. and Reed J. FAP-1: a protein tyrosine phosphatase that associates with Fas. Science 268: 411 (1995).
72. Boldin M.P.. Varfoloneef E.E., PancerZ., Mett I., Camonis J. and Wallach D. A novel protein that interacts with the death domain of Fas/APO-1 contains a sequence motif related to the death domain. J. Biol. Chem. 270: 7795 (1995).
73. Cohen P.L., and Eisenberg R.A. The Ipr and gld genes in systemic autoimmunity: Life and death in the Fas lane. Immunol. Today 13: 427 (1992).
74. Wu J.. Zhou T.. He J. and Mountz J.D. Autoimmune disease in mice due to integration of an endogenous retrovirus in an apoptosis gene. J. Exp. Med. 178: 461 (1993).
75. Chu J-L., Drappa J., Parnnasa A., and Elkon K.B. The defect in fas mRNA expressed in MRL/lpr is associated with insertion of the retrotransposon, Etn. J. Exp. Med. 178: 723 (1994).
76. Adachi M., Watanabe-Fukunaga R. & Nagata S. Aberrant transcription caused by the insertion of an early transposable element in an intron of the Fas antigen gene of Ipr mice. Proc. Natl . Acad. Sei. (USA) 90: 1756(1993).
77. Watanabe-Fukunaga R., Brannan C.I., Copeland N.G., Jenkins N.A.. and Nagata S. Lymphopoliferation disorder in mice explained by defects in Fas antigen that mediate apoptosis. Nature 356: 3 14 ( 1992).
78. Wu J.. Zhou T.. Zhang J., He J.. Cause W.C. and Mountz J.D. Correction of accelerated autoimmune disease by early replacement of the mutated Ipr gene with the normal/as apoptosis gene in the T cells of transgenic MRL-lpr/lpr mice. Proc. Natl. Acad. Sei. (USA) 91: 2344(1994).
79. Suda T., Takahashi T.. Golstein P., & Nagata S. Molecular cloning and expression of Fas ligand, a novel member of the tumor necrosis factor family. Cell 75: 1169 (1992).
80. Takahashi T.. Tanaka M., Inazawa J.. Abe T., Suda T., & Nagata S. Human Fas ligand: gene structure, chromosome location and species specificity. Int. Immunol. 6: 1567 (1994).
81. Suda T. and Nagata S. Purification and characterization of the Fas ligand that induces apoptosis. J. Exp. Med. 179: 873 (1994).
82. Takahashi T., Tanaka M., Brannan C.I., Jenkin N.A., Copeland N.G., Suda T., and Nagata S. Generalized lymphoprolireative disease in mice, caused by a point mutation in the Fas ligand. Cell 76: 969 ( 1994).
83. Rieux-Laucat F., Le Diest F., Hivroz C., Roberts I.A., Debatin K.M., Fischer A., and de Villartay J.P. Mutation in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 268: 1347 (1995).
84. Fisher G.H.. Rosenberg F.J., Straus S.. Dale J.. Middelton L.A., Lin A.Y., Strober W., Lenardo M., and Puck J.M. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 81: 935 (1995).
85. Kashahara T.. Wada Y, Niida I., Ohno A., Yachie H., Seki T., Miyawaki N., and Taniguchi N. Human lymphoproliferative disease associated with FAS mutation. The FASEB J. 10 (6): A1063, 1996
86. Liu Z.G., Smith S.W., McLaughlin K.A.. Schwartz L.M. and Osborne B.A. Apoptotic signals delivered through the T-cell receptor of a T-cell hybrid require the immediate-early gene nur 77. Nature 367: 281 (1994).
87. Woronicz J.D., Calnan B., Ngo V, and Winoto A. Requirement for the orphan steroid receptor Nur77 in apoptosis of T cell hybridomas. Nature 367: 277 (1994).
88. Okabe T.. Takayanagi R., Imasaki K., Haji M., Nawata H., and Watnabe T. cDNA cloning of a NGFl-B/nur77-related transcription factor from an apoptotic human T cell line. J. Immunol. 154: 3871-3879. 1995.